A Trial Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Semaglutide (Primary) ; Omeprazole
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 08 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 01 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.